John Oyler, Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 6,054 shares at $255.74 ($1.5M) on 2025-06-06, disclosed to the SEC on 2025-06-10.
Open-market sale of $1.5M ONC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $250.84 | 1,400 | $351K | 22.9% |
| 2 | $251.88 | 1,400 | $353K | 23.0% |
| 3 | $253.49 | 1,000 | $253K | 16.5% |
| 4 | $254.97 | 927 | $236K | 15.4% |
| 5 | $254.97 | 927 | $236K | 15.4% |
| 6 | $255.74 | 400 |
| $102K |
| 6.7% |
| Total | $253.11 avg | 6,054 | $1.5M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-14 | $18.3M | — | Filing → |